How has the fund performed?
where the fund invests
basic facts
- Launch date: 26 December 2007
- Category: Equity
- Type: Mid Cap
- AUM (as on 30 September 2021): Rs 1,707 crore
- Benchmark: Nifty Midcap 100 Total Return Index
What is the rate
are not (on November 1, 2021)
- Growth Option: Rs 51.14
- IDCW: Rs 31.57
- Minimum investment: Rs 5,000
- Minimum SIP amount: Rs 500
- Expenditure Ratio (as on 30 September 2021) (%): 2.11
- Exit Load: 1% for redemption within 365 days
Fund Manager: Harshad Patwardhan
Tenure: 14 years
Top 5 Sectors in Portfolio (%)
top 5 shares Portfolio (%)
Recent portfolio changes
- full exit: Kansai Nerolac Paints, Voltas, NCC.
- Increase allocation: Zydus Wellness, Max Financial Services, Ashok Leyland, Max Healthcare, Naveen Fluorine, Tata Power, Shriram Transport Finance, Crompton Greaves Consumer Electricals, Trent, Emami.
How risky is it?
Source: Value Research
should you buy
This fund realized its mandate from mid- and small-cap to mid-cap a few years back. As a result, the small-cap presence was reduced initially, but has been increased again while maintaining the mid-cap focus. It is guided by evolving market conditions. Compared to the past, the fund also takes a good position in its top bets, allowing for meaningful exposure to high-confidence ideas. The fund manager also lays emphasis on ensuring high liquidity in the portfolio. This fund has been pretty consistent in delivering alpha over the years. After seeing a brief decline in 2018, it has been in the top quartile in its category in recent years. Its track record under the leadership of its experienced fund manager provides comfort over the long term.